Zealth

Zealth launched their MVP as a simple SMS-based symptom tracking system that cancer patients could access from any phone, deliberately omitting complex AI diagnostics and integration with hospital EHR systems. ​​‌‌‌‌‌‌‌​‌‌​​‌​​​​​​‌‌​‌‌‌​​​‌‌They shipped their first version within eight weeks, focusing exclusively on post-discharge monitoring for oncology patients at two partner hospitals in India. This stripped-down approach meant patients reported side effects through basic text prompts, with alerts escalating to nurses only when thresholds were exceeded. Early validation came quickly: within three months, they reduced hospital readmissions by 23% and cut patient travel time by 40%. The constraint of SMS-only delivery actually became an advantage—it worked across India's fragmented telecom infrastructure without requiring smartphones. However, this simplicity later created friction when hospitals wanted deeper data integration. Zealth's execution prioritized solving the immediate access problem over building comprehensive infrastructure, which validated their core insight that even basic remote monitoring dramatically improved outcomes in resource-constrained settings.